Organogenesis Launches Regenerative Medicine College S... (xpansion of its U.S. headquarters. For ...)

(Date:11/27/2009)... The Gymboree Corporation...O/COO, will present at the NASDAQ OMX 23rd Investo...l in London, England, on Wednesday, December 2, 20...roadcast of The Gymboree Corporation,s presentatio....com, click on "Our Company" at the bottom of the ...

(Date:11/27/2009)... Holdings has announced that it has become a natio...e largest nonprofit organizations dedicated to art... Delray Beach, FL (Vocus) Nov...XCHO), a company specializing in the marketing and...ts, has announced today that is has become a natio...

(Date:11/27/2009)...ealth™ announced today that Spectrum Health ...d Enterprise orthopedic templating solution and it... (PRWEB) November 27, 2009 -- Voyant...h (Grand Rapids, Michigan) has licensed its Trauma...its TraumaCad Extend workflow solution, to allow i...

(Date:11/26/2009)...ewswire/ -- With cold and flu season upon us, it,s... to control the spread of infections and avoid ill...eep ourselves healthy, but to avoid transmitting i..., CIC (certified in infection-control), nursing di...th at Hospital for Special Surgery (HSS) in Manhat...

(Date:11/26/2009)...y can lead to strains or worse , , THURS...ing wrong with stuffing your turkey full to bursti...th your suitcase as you pack for holiday trips. ,... U.S. hospital emergency rooms, doctors, offices, ...elated injuries, such as muscle strains, pulls and...

Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4 Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2 Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4 Health News:Pack Right for the Holidays to Avoid the ER 2

[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program [0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation [0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend [1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use [2] Pack Right for the Holidays to Avoid the ER

...e heart failure is the most frequent cause of hosp...ult to diagnose.// Treatment delays increase the c...sts of care. Already, doctors in many emergency...ch the heart stops pumping effectively. The su...

...lure is a chronic but deadly condition caused by t...ually enlarges as it becomes weaker and weaker. ...n, which will kill half of them within five years....ients who took statins ( work by reducing inflamma...

...rch shows older women with depression may have an ...archers in New York studied more than 93,600 older...iative Observational Study (WHI-OS). The WHI-OS is...ealth conditions. For this study, participants wer...

...d, skin cancers cause 16,000 deaths each year due ... body. // Previously, the best way to predict whe...g its thickness. It was believed the thicker a tum... found a new way to predict whether skin cancers w...

... to a recent study by Taiwanese experts , people b...getting virtually none. St John's Wort, or Hype...ugh doctors warn it can interfere with the effects... to be responsible for the psychoactive effects of...

...sia usually occurs without warning when a woman de...nancy.// About 5 percent of pregnant women are aff...e protein in their urine. If the condition progres...ndition, only delivery of the baby can resolve the...

Other Medicine News:Health News:‘Protein’ Produced By Overstressed Heart Muscle a Strong Indicator Of Heart Disea 2 Health News:Predicting The Risk Of Preeclampsia During Pregnancy 2

‘Protein’ Produced By Overstressed Heart Muscle a Strong Indicator Of Heart Disea Cholesterol-lowering drug Found To greatly Reduce the risk of stroke and heart attack Elderly Women With Depression More Prone to Heart Disease New Way to Detect Spread of Skin Cancer Variations In ingredients From Brand to Brand Predicting The Risk Of Preeclampsia During Pregnancy

(Date:11/25/2009)...XTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGrou...lara report,thefirstinamulti-phasesyndicatedmarke...iotech,sStelara,fromproductlaunchthroughthefirstsi...uantitativeinformationfrom75uniqueDermatologistsan...ssesstrialanduseofStelara,obstaclestouse,typicalpa...

(Date:11/25/2009)..., COLLEGE PARK, Md., Nov. 25 /PRNewswire-USNews...eloping a shaving cream-like foam that stops sever...t Promising Security Idea category of the Global S... today. ,, Selected from more than 100 entries ...ir invention at the GSC Security Summit conference...

(Date:11/25/2009)... , HARBIN, China, Nov. 25 /PRNewswire-Asi...a Sky One Medical" or "the Company") (Nasdaq: CSK...pany developing and producing,over-the-counter dru...y,announced that the Company recently passed the C...aceutical and Biological Products ("ICPBP") examin...

Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2 Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2 Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3 China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2 China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3 Strong link found between concussions and brain tissue injury 55150 1 Strong link found between concussions and brain tissue injury 55150 2 Strong link found between concussions and brain tissue injury 55150 3 Searching for an interglacial on Greenland 9684 1 Searching for an interglacial on Greenland 9684 2 Diplomat Specialty Pharmacy Partners With CareSource Launches Chronic Kidney Disease Management Program with Ohio Plan 55146 1 Diplomat Specialty Pharmacy Partners With CareSource Launches Chronic Kidney Disease Management Program with Ohio Plan 55146 2

[0] Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High [0] Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam [0] China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits

...Lower Incidence of Severe Cardiac Toxicity With Eq...s Reported, ATLANTA, Dec. 11 Cell Therapeutics, ... that preliminary data from,its phase II/III rando...t-line treatment of patients with aggressive non-H...ed pixantrone experienced less severe,(grade 3/4) ...

...tion aimed at enabling vaccine production facility...tional egg-based facility., * Once established, s...f, pandemic flu vaccine to commence within 12 wee...gland and ROCKVILLE, Md., Dec. 10, GE Healthcare, ...nd Novavax Inc. (Nasdaq: NVAX ), today announced ...

Other Medicine Technology:Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2 Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3 Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4 Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5 GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 2 GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 3 GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 4

Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution

...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...

Medicine Products:

Pb, Blood Paxil Partial Thromboplastin Time with Reflex to PTT 1:1 Mix Partial Thromboplastin Time

Organogenesis Launches Regenerative Medicine College S...(xpansion of its U.S. headquarters. For ...),Health